Last10K.com

Lifepoint Health, Inc. (LPNT) SEC Filing 10-Q Quarterly report for the period ending Sunday, September 30, 2018

Lifepoint Health, Inc.

CIK: 1301611 Ticker: LPNT

Exhibit 99.1

LifePoint Health Reports Third Quarter 2018 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--October 26, 2018--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the third quarter and nine months ended September 30, 2018.

Third Quarter 2018

The following highlights the Company’s results of operations as presented in accordance with U.S. generally accepted accounting principles (“GAAP”) for the third quarter ended September 30, 2018:

  • Same-hospital revenues totaled $1,548.5 million, an increase of 2.1% compared to the same period last year;
  • Net income totaled $23.3 million;
  • Diluted earnings per share attributable to LifePoint Health, Inc. stockholders were $0.56; and
  • Net cash provided by operating activities totaled $162.9 million, an increase of $71.8 million, or 78.8%, compared to the same period last year.

The Company’s results of operations for the third quarters ended September 30, 2018 and 2017, included the following non-operational adjustments:

  • For the third quarter of 2018, the Company recognized losses in the aggregate of $40.1 million, or $0.77 loss per diluted share, comprised of an impairment loss recognized in connection with the Company’s entry into a proposed settlement agreement to terminate its lease and operation of a hospital campus located in Louisiana and the recognition of merger-related expenses;
  • Also, for the third quarter of 2018, the Company recognized additional salaries and benefits expense of $21.6 million, or $0.50 loss per diluted share, related to the acceleration of the vesting of outstanding stock-based awards for the Company’s chief executive officer, as a result of his announced retirement;
  • Lastly, for the third quarter of 2018, the Company recognized a deferred tax benefit of $23.6 million, or $0.59 earnings per diluted share, related to a tax accounting method change for recognizing the tax deductibility of certain self-pay revenues; and
  • For the third quarter of 2017, the Company recognized a net gain of $3.7 million, or $0.13 loss per diluted share when adjusted for the impact of income taxes, comprised of a gain related to the transfer of certain of the Company’s home health agencies and hospices to In-Home Healthcare Partnership (“IHHP”), a joint venture with LHC Group, Inc., which the Company does not consolidate, and an impairment loss for the write-off of allocated goodwill in connection with the sale of a hospital campus located in Georgia.

Excluding the non-operational adjustments listed above, highlights of the Company’s results of operations, as adjusted on a non-GAAP basis, for the third quarter ended September 30, 2018, were as follows:

  • Normalized net income totaled $50.3 million;
  • Normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders were $1.24; and
  • Normalized EBITDA totaled $183.3 million.

Additional information regarding normalized net income, normalized diluted earnings per share attributable to LifePoint Health, Inc. stockholders, adjusted EBITDA and normalized EBITDA, including uses by management and others, and a reconciliation to comparable GAAP measures of financial performance, is set forth under the section titled “Unaudited Supplemental Information.”


The following information was filed by Lifepoint Health, Inc. (LPNT) on Friday, October 26, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Lifepoint Health, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Lifepoint Health, Inc..

Continue

Assess how Lifepoint Health, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Lifepoint Health, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Legal
Other
Filter Subcategory:
All
Expense
Earnings
Income
Cash Flow
Product
Shares
Geography
Debt
Other
Inside Lifepoint Health, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statement Of Stockholders' Equity
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Income
Commitments And Contingencies
Commitments And Contingencies (Narrative) (Details)
Common Stock In Treasury
Common Stock In Treasury (Narrative) (Details)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Narrative) (Details)
Fair Value Of Financial Instruments (Schedule Of Carrying Amount And Fair Value) (Details)
Fair Value Of Financial Instruments (Tables)
General And Administrative Costs
General And Administrative Costs (Narrative) (Details)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (Narrative) (Details)
Goodwill And Intangible Assets (Schedule Of Intangible Assets) (Details)
Goodwill And Intangible Assets (Tables)
Guarantor And Non-Guarantor Supplementary Information
Guarantor And Non-Guarantor Supplementary Information (Narrative) (Details)
Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Balance Sheets) (Details)
Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Statements Of Cash Flows) (Details)
Guarantor And Non-Guarantor Supplementary Information (Schedule Of Condensed Consolidating Statements Of Operations) (Details)
Guarantor And Non-Guarantor Supplementary Information (Tables)
Income Taxes
Income Taxes (Narrative) (Details)
Income Taxes (Schedule Of Provision For Income Taxes) (Details)
Income Taxes (Tables)
Organization, Basis Of Presentation And Recently Issued Accounting Standards
Organization, Basis Of Presentation And Recently Issued Accounting Standards (Narrative) (Details)
Organization, Basis Of Presentation And Recently Issued Accounting Standards (Policy)
Other Non-Operating Losses (Gains), Net
Other Non-Operating Losses (Gains), Net (Narrative) (Details)
Other Non-Operating Losses (Gains), Net (Summary Of Items Included Under Other Non-Operating Losses (Gains), Net) (Details)
Other Non-Operating Losses (Gains), Net (Tables)
Redeemable Noncontrolling Interests
Redeemable Noncontrolling Interests (Narrative) (Details)
Redeemable Noncontrolling Interests (Schedule Of Changes In Redeemable Noncontrolling Interests) (Details)
Redeemable Noncontrolling Interests (Tables)
Revenue Recognition And Accounts Receivable
Revenue Recognition And Accounts Receivable (Narrative) (Details)
Revenue Recognition And Accounts Receivable (Schedule Of Revenues By Payer And Approximate Percentages Of Revenues) (Details)
Revenue Recognition And Accounts Receivable (Schedule Of Revenues By Primary Service Type And Approximate Percentages Of Revenues) (Details)
Revenue Recognition And Accounts Receivable (Schedule Of Revenues By State And Approximate Percentages Of Revenues) (Details)
Revenue Recognition And Accounts Receivable (Tables)
Stock-Based Compensation
Stock-Based Compensation (Narrative) (Details)
Stock-Based Compensation (Schedule Of Estimates Of Weighted-Average Fair Value Per Share Of Stock Options Granted) (Details)
Stock-Based Compensation (Schedule Of Total Stock-Based Compensation Expense And Total Recognized Tax Benefits) (Details)
Stock-Based Compensation (Tables)
Ticker: LPNT
CIK: 1301611
Form Type: 10-Q Quarterly Report
Accession Number: 0001301611-18-000017
Submitted to the SEC: Fri Oct 26 2018 11:20:18 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Sunday, September 30, 2018
Industry: General Medical And Surgical Hospitals

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/lpnt/0001301611-18-000017.htm